Cargando…
Human CD1c(+) DCs are critical cellular mediators of immune responses induced by immunogenic cell death
Chemotherapeutics, including the platinum compounds oxaliplatin (OXP) and cisplatin (CDDP), are standard care of treatment for cancer. Although chemotherapy has long been considered immunosuppressive, evidence now suggests that certain cytotoxic agents can efficiently stimulate antitumor responses,...
Autores principales: | Di Blasio, Stefania, Wortel, Inge M. N., van Bladel, Diede A. G., de Vries, Laura E., Duiveman-de Boer, Tjitske, Worah, Kuntal, de Haas, Nienke, Buschow, Sonja I., de Vries, I. Jolanda M., Figdor, Carl G., Hato, Stanleyson V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007971/ https://www.ncbi.nlm.nih.gov/pubmed/27622063 http://dx.doi.org/10.1080/2162402X.2016.1192739 |
Ejemplares similares
-
The chemotherapeutic drug oxaliplatin differentially affects blood DC function dependent on environmental cues
por: Tel, Jurjen, et al.
Publicado: (2011) -
STAT Family Protein Expression and Phosphorylation State during moDC Development Is Altered by Platinum-Based Chemotherapeutics
por: de Haas, Nienke, et al.
Publicado: (2019) -
Improving cancer immunotherapy by targeting the STATe of MDSCs
por: de Haas, Nienke, et al.
Publicado: (2016) -
Preclinical exploration of combining plasmacytoid and myeloid dendritic cell vaccination with BRAF inhibition
por: Tel, Jurjen, et al.
Publicado: (2016) -
Clinical Implications of Co-Inhibitory Molecule Expression in the Tumor Microenvironment for DC Vaccination: A Game of Stop and Go
por: Vasaturo, Angela, et al.
Publicado: (2013)